×

Capital Goods Industrial Traders and Distributors

  • Sept 7- New Mexico on Thursday sued eight opioid manufacturers and wholesale distributors, becoming the latest state or local government to file a lawsuit seeking to hold corporations accountable for a national drug addiction epidemic. New Mexico Attorney General Hector Balderas accused Purdue Pharma LP, Johnson& Johnson, Allergan Plc, Endo International...

  • Sept 7- New Mexico on Thursday sued eight opioid manufacturers and wholesale distributors, becoming the latest state or local government to file a lawsuit seeking to hold corporations accountable for a national drug addiction epidemic. New Mexico Attorney General Hector Balderas accused Purdue Pharma LP, Johnson& Johnson, Allergan Plc, Endo International...

  • *Q1 adj. earnings of $2.46/ share vs est of $2.83/ share. *Raises fiscal 2018 earnings forecast to $11.80- $12.50/ share. "We entered this year with an assumption of branded inflation in the mid-single digits, and our first quarter experience was slightly ahead of this assumption," McKesson Chief Executive John Hammergren said.

  • Leerink analyst David Larsen noted that the company's distribution business performance was a significant surprise given commentary around a stabilizing environment in independent pharmacy networks and improving sentiment around brand pricing. Net income attributable to McKesson fell to $309 million, or $1.45 per share, in the first quarter ended...

  • Net income attributable to McKesson fell to $309 million, or $1.45 per share, in the first quarter ended June 30, from $542 million, or $2.38 per share, a year earlier. Excluding items, the company earned $2.46 cents per share, below analysts' average estimate of $2.83, according to Thomson Reuters I/B/E/S. Revenue rose nearly 3 percent to $51.05 billion, missing...

  • *China business had over $3.5 bln revenue last year. *Cardinal sale move comes amid China drug distribution reform. HONG KONG, July 20- U.S. drug distributor Cardinal Health has put its China business up for sale, drawing keen interest from state-backed Chinese pharmaceutical firms in a deal that may be worth up to $1.5 billion, sources familiar with the matter said.

  • *Q1 earnings $1.77/ shr vs estimate of $1.68/ shr. *Raised fiscal 2017 adjusted earnings to $5.77 to $5.92 per share. Leerink Partners analyst David Larsen said the unchanged drug pricing forecast bodes well for fiscal 2018, adding that operating margins for the quarter have been partly hurt by more rapid brand to generic conversions and not pricing.

  • April 27- Duracell, a unit of Warren Buffett's Berkshire Hathaway Inc, on Thursday filed a lawsuit accusing a Missouri wholesaler of illegally selling gray market versions of its copper-top alkaline batteries. According to a complaint filed in federal court in Chicago, JRS Ventures Inc is importing and selling batteries made in China that were intended for...

  • Industrial production down 0.4% in August

    CNBC's Rick Santelli reports the latest industrial production data.

  • Two employees tie up steel bars at a steel-making plant in Ganyu, China.

    Profits earned by Chinese industrial companies fell 4.6 percent in October from a year earlier, data from the statistics bureau showed on Friday.

  • Tourists wear masks as a precaution against the MERS virus at the Incheon International Airport in South Korea.

    South Korea's industrial output declined sharply with production losses across key automobile, semiconductor and machinery sectors.